1409 related articles for article (PubMed ID: 25645252)
21. Distinct loading conditions reveal various patterns of right ventricular adaptation.
Borgdorff MA; Bartelds B; Dickinson MG; Steendijk P; de Vroomen M; Berger RM
Am J Physiol Heart Circ Physiol; 2013 Aug; 305(3):H354-64. PubMed ID: 23729212
[TBL] [Abstract][Full Text] [Related]
22. Copaiba Oil Attenuates Right Ventricular Remodeling by Decreasing Myocardial Apoptotic Signaling in Monocrotaline-Induced Rats.
Campos-Carraro C; Turck P; de Lima-Seolin BG; Tavares AMV; Dos Santos Lacerda D; Corssac GB; Teixeira RB; Hickmann A; Llesuy S; da Rosa Araujo AS; Belló-Klein A
J Cardiovasc Pharmacol; 2018 Nov; 72(5):214-221. PubMed ID: 30212415
[TBL] [Abstract][Full Text] [Related]
23. Antioxidant treatment attenuates pulmonary arterial hypertension-induced heart failure.
Redout EM; van der Toorn A; Zuidwijk MJ; van de Kolk CW; van Echteld CJ; Musters RJ; van Hardeveld C; Paulus WJ; Simonides WS
Am J Physiol Heart Circ Physiol; 2010 Mar; 298(3):H1038-47. PubMed ID: 20061549
[TBL] [Abstract][Full Text] [Related]
24. Neuregulin-1 improves right ventricular function and attenuates experimental pulmonary arterial hypertension.
Mendes-Ferreira P; Maia-Rocha C; Adão R; Mendes MJ; Santos-Ribeiro D; Alves BS; Cerqueira RJ; Castro-Chaves P; Lourenço AP; De Keulenaer GW; Leite-Moreira AF; Brás-Silva C
Cardiovasc Res; 2016 Jan; 109(1):44-54. PubMed ID: 26503987
[TBL] [Abstract][Full Text] [Related]
25. Downregulation of MicroRNA-126 Contributes to the Failing Right Ventricle in Pulmonary Arterial Hypertension.
Potus F; Ruffenach G; Dahou A; Thebault C; Breuils-Bonnet S; Tremblay È; Nadeau V; Paradis R; Graydon C; Wong R; Johnson I; Paulin R; Lajoie AC; Perron J; Charbonneau E; Joubert P; Pibarot P; Michelakis ED; Provencher S; Bonnet S
Circulation; 2015 Sep; 132(10):932-43. PubMed ID: 26162916
[TBL] [Abstract][Full Text] [Related]
26. Pioglitazone alleviates cardiac and vascular remodelling and improves survival in monocrotaline induced pulmonary arterial hypertension.
Behringer A; Trappiel M; Berghausen EM; Ten Freyhaus H; Wellnhofer E; Odenthal M; Blaschke F; Er F; Gassanov N; Rosenkranz S; Baldus S; Kappert K; Caglayan E
Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr; 389(4):369-79. PubMed ID: 26742933
[TBL] [Abstract][Full Text] [Related]
27. Pulmonary arterial hypertension induced by a novel method: Twice-intraperitoneal injection of monocrotaline.
Zhuang W; Lian G; Huang B; Du A; Xiao G; Gong J; Xu C; Wang H; Xie L
Exp Biol Med (Maywood); 2018 Aug; 243(12):995-1003. PubMed ID: 30099957
[TBL] [Abstract][Full Text] [Related]
28. Macrophage-NLRP3 Activation Promotes Right Ventricle Failure in Pulmonary Arterial Hypertension.
Al-Qazazi R; Lima PDA; Prisco SZ; Potus F; Dasgupta A; Chen KH; Tian L; Bentley RET; Mewburn J; Martin AY; Wu D; Jones O; Maurice DH; Bonnet S; Provencher S; Prins KW; Archer SL
Am J Respir Crit Care Med; 2022 Sep; 206(5):608-624. PubMed ID: 35699679
[No Abstract] [Full Text] [Related]
29. Right Ventricular Fibrosis.
Andersen S; Nielsen-Kudsk JE; Vonk Noordegraaf A; de Man FS
Circulation; 2019 Jan; 139(2):269-285. PubMed ID: 30615500
[TBL] [Abstract][Full Text] [Related]
30. Epigenetic Metabolic Reprogramming of Right Ventricular Fibroblasts in Pulmonary Arterial Hypertension: A Pyruvate Dehydrogenase Kinase-Dependent Shift in Mitochondrial Metabolism Promotes Right Ventricular Fibrosis.
Tian L; Wu D; Dasgupta A; Chen KH; Mewburn J; Potus F; Lima PDA; Hong Z; Zhao YY; Hindmarch CCT; Kutty S; Provencher S; Bonnet S; Sutendra G; Archer SL
Circ Res; 2020 Jun; 126(12):1723-1745. PubMed ID: 32216531
[TBL] [Abstract][Full Text] [Related]
31. Exercise facilitates early recognition of cardiac and vascular remodeling in chronic thromboembolic pulmonary hypertension in swine.
Stam K; van Duin RWB; Uitterdijk A; Cai Z; Duncker DJ; Merkus D
Am J Physiol Heart Circ Physiol; 2018 Mar; 314(3):H627-H642. PubMed ID: 29167118
[TBL] [Abstract][Full Text] [Related]
32. Ischemia-induced Drp1 and Fis1-mediated mitochondrial fission and right ventricular dysfunction in pulmonary hypertension.
Tian L; Neuber-Hess M; Mewburn J; Dasgupta A; Dunham-Snary K; Wu D; Chen KH; Hong Z; Sharp WW; Kutty S; Archer SL
J Mol Med (Berl); 2017 Apr; 95(4):381-393. PubMed ID: 28265681
[TBL] [Abstract][Full Text] [Related]
33. PRX-08066, a novel 5-hydroxytryptamine receptor 2B antagonist, reduces monocrotaline-induced pulmonary arterial hypertension and right ventricular hypertrophy in rats.
Porvasnik SL; Germain S; Embury J; Gannon KS; Jacques V; Murray J; Byrne BJ; Shacham S; Al-Mousily F
J Pharmacol Exp Ther; 2010 Aug; 334(2):364-72. PubMed ID: 20430844
[TBL] [Abstract][Full Text] [Related]
34. Percutaneous Carbon Dioxide Treatment Using a Gas Mist Generator Attenuates the Development of Right Ventricular Dysfunction in Monocrotaline-induced Pulmonary Hypertensive Rats.
Yamaguchi T; Izumi Y; Yamazaki T; Nakamura Y; Sano S; Shiota M; Miura K; Iwao H; Yoshiyama M
Osaka City Med J; 2015 Jun; 61(1):31-41. PubMed ID: 26434103
[TBL] [Abstract][Full Text] [Related]
35. 2-Methoxyestradiol mediates the protective effects of estradiol in monocrotaline-induced pulmonary hypertension.
Tofovic SP; Zhang X; Jackson EK; Dacic S; Petrusevska G
Vascul Pharmacol; 2006 Dec; 45(6):358-67. PubMed ID: 16872912
[TBL] [Abstract][Full Text] [Related]
36. Mitochondrial function remains impaired in the hypertrophied right ventricle of pulmonary hypertensive rats following short duration metoprolol treatment.
Power AS; Norman R; Jones TLM; Hickey AJ; Ward ML
PLoS One; 2019; 14(4):e0214740. PubMed ID: 30964911
[TBL] [Abstract][Full Text] [Related]
37. Pathophysiology of infantile pulmonary arterial hypertension induced by monocrotaline.
Dias-Neto M; Luísa-Neves A; Pinho S; Gonçalves N; Mendes M; Eloy C; Lopes JM; Gonçalves D; Ferreira-Pinto M; Leite-Moreira AF; Henriques-Coelho T
Pediatr Cardiol; 2015 Jun; 36(5):1000-13. PubMed ID: 25608696
[TBL] [Abstract][Full Text] [Related]
38. Activation of the nicotinamide N-methyltransferase (NNMT)-1-methylnicotinamide (MNA) pathway in pulmonary hypertension.
Fedorowicz A; Mateuszuk Ł; Kopec G; Skórka T; Kutryb-Zając B; Zakrzewska A; Walczak M; Jakubowski A; Łomnicka M; Słomińska E; Chlopicki S
Respir Res; 2016 Aug; 17(1):108. PubMed ID: 27581040
[TBL] [Abstract][Full Text] [Related]
39. Pulmonary arterial hypertension reduces energy efficiency of right, but not left, rat ventricular trabeculae.
Pham T; Nisbet L; Taberner A; Loiselle D; Han JC
J Physiol; 2018 Apr; 596(7):1153-1166. PubMed ID: 29363144
[TBL] [Abstract][Full Text] [Related]
40. Pressure overload-induced right ventricular failure is associated with re-expression of myocardial tenascin-C and elevated plasma tenascin-C levels.
Hessel M; Steendijk P; den Adel B; Schutte C; van der Laarse A
Cell Physiol Biochem; 2009; 24(3-4):201-10. PubMed ID: 19710535
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
